NFKB1 and COVID-19: This nanocage structure primarily accumulated in the lungs and kidneys in a mouse model, and it suppressed NF-κB activity and cytokine production in peripheral blood mononuclear cells from patients with severe COVID-19 and rescued the survival rate of septic mouse models that are used for studying cytokine storm97.